Trial Design Finalized in Consultation and Alignment with U.S. Food and Drug Administration Study Designed to Establish a New Standard for Adult ...
Scientists engineered phages to act as scaffolds to carry silver nanoparticles. Together, the two bacteria-killing components ...
Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that the province of Saskatchewan has added CAPVAXIVE®, a 21-valent pneumococcal conjugate vaccine, to its ...
Learn why child mortality is rising for the first time in our lives - and how smarter investments, innovation, and science ...
Pneumonia cases surge in winter as cold, pollution, and viruses weaken immunity. Dr. Agrawal urges early diagnosis, awareness ...
Kite, a Gilead Company , presented a new analysis today demonstrating that second-line Yescarta® (axicabtagene ciloleucel) therapy offers consistent benefits in patients with relapsed/refractory large ...
OS Therapies Inc. (NYSE American: OSTX) (“OS Therapies” or “the Company”), the world leader in listeria-based cancer ...
AstraZeneca advances its ambition to redefine hematology care with new data from its diverse pipeline and portfolio at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback